VeriMom¿Debo evitar ci 77947 durante el embarazo? | VeriMom
Zinc oxide (CI 77947, CAS 1314-13-2) has no harmonised reproductive classification (ECHA Annex VI lists only environmental classifications H400/H410). Authoritative cosmetic panels (e.g., SCCS/CIR) regard zinc oxide as safe for topical use in cosmetics/sunscreens under their conditions; systemic dermal absorption is minimal, so reproductive hazard and exposure during pregnancy are not indicated. Note: some non‑harmonised notifications (e.g., aggregated PubChem GHS entries) include H361, but these are self-notifications/aggregations and are not harmonised and thus do not override higher-priority sources.
ECHA regulatory hazard statements
- •H400
- •H410
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- ¿Es ci 77947 seguro durante el embarazo?
- Zinc oxide (CI 77947, CAS 1314-13-2) has no harmonised reproductive classification (ECHA Annex VI lists only environmental classifications H400/H410). Authoritative cosmetic panels (e.g., SCCS/CIR) regard zinc oxide as safe for topical use in cosmetics/sunscreens under their conditions; systemic dermal absorption is minimal, so reproductive hazard and exposure during pregnancy are not indicated. Note: some non‑harmonised notifications (e.g., aggregated PubChem GHS entries) include H361, but these are self-notifications/aggregations and are not harmonised and thus do not override higher-priority sources.
- ¿Es ci 77947 seguro durante la lactancia?
- Because dermal/systemic absorption of zinc oxide from topical formulations is negligible under normal use (per SCCS/CIR assessments), maternal systemic exposure that could transfer to breast milk is not expected. No authoritative evidence of reproductive/lactational toxicity from harmonised classifications.
- ¿Es ci 77947 seguro para la piel del bebé?
- Hazard and mechanism: no infant-specific reproductive/toxic mechanism identified. Exposure: while adult dermal absorption is negligible, zinc oxide is not absolutely non-absorbable and infants (0–3 yr) have an immature skin barrier/higher surface‑area‑to‑body‑weight, so exposure score is increased by +1 relative to adults. SCCS/CIR accept topical use (including in sunscreens and barrier creams) given minimal systemic uptake, but infant-specific absorption data are limited.
- ¿Cómo puntúa VeriMom a ci 77947?
- VeriMom puntúa ci 77947 en 39/100 (riesgo alto) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a ci 77947 en el embarazo?
- Consulta nuestra lista de alternativas seguras a ci 77947 según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.